Patents by Inventor Michiel Ullmann

Michiel Ullmann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMBINATIONS OF FORMOTEROL AND BUDESONIDE FOR THE TREATMENT OF COPD
    Publication number: 20170209464
    Abstract: This invention provides a fixed-dose composition comprising formoterol or a pharmaceutically acceptable salt thereof and budesonide, for use in the long-term treatment of COPD and the treatment of acute exacerbations of COPD, wherein the composition is administered as a maintenance dose for the long-term treatment of COPD and pro re nata (p.r.n.) as a rescue medication for the treatment of acute exacerbations of COPD.
    Type: Application
    Filed: May 8, 2015
    Publication date: July 27, 2017
    Applicant: Teva Pharmaceuticals Europe B.V.
    Inventor: Michiel ULLMANN
  • COMBINATIONS OF TIOTROPIUM BROMIDE, FORMOTEROL AND BUDESONIDE FOR THE TREATMENT OF COPD
    Publication number: 20170202858
    Abstract: This invention provides a combination product comprising an inhalable long-acting muscarinic antagonist (LAMA) composition for use in the long-term treatment of COPD combined with an inhalable fixed-dose composition comprising budesonide and formoterol or a pharmaceutically acceptable salt thereof for administration pro re nata (prn) as a rescue medication for the treatment of acute exacerbations of COPD.
    Type: Application
    Filed: May 8, 2015
    Publication date: July 20, 2017
    Applicant: Teva Pharmaceuticals Europe B.V.
    Inventor: Michiel ULLMANN
  • Respiratory apparatus
    Patent number: D782650
    Type: Grant
    Filed: April 7, 2014
    Date of Patent: March 28, 2017
    Assignee: TEVA Pharmaceutical Industries Limited
    Inventors: Mark Milton-Edwards, Michiel Ullmann
  • Respiratory apparatus
    Patent number: D782651
    Type: Grant
    Filed: April 7, 2014
    Date of Patent: March 28, 2017
    Assignee: TEVA Pharmaceutical Industries Limited
    Inventors: Mark Milton-Edwards, Michiel Ullmann
  • Respiratory apparatus
    Patent number: D782652
    Type: Grant
    Filed: April 7, 2014
    Date of Patent: March 28, 2017
    Assignee: TEVA Pharmaceutical Industries Limited
    Inventors: Mark Milton-Edwards, Michiel Ullmann
  • Respiratory apparatus
    Patent number: D783156
    Type: Grant
    Filed: April 7, 2014
    Date of Patent: April 4, 2017
    Assignee: TEVA Pharmaceutical Industries Limited
    Inventors: Mark Milton-Edwards, Michiel Ullmann
  • Respiratory apparatus
    Patent number: D783157
    Type: Grant
    Filed: April 7, 2014
    Date of Patent: April 4, 2017
    Assignee: TEVA Pharmaceutical Industries Limited
    Inventors: Mark Milton-Edwards, Michiel Ullmann
  • Respiratory apparatus
    Patent number: D783158
    Type: Grant
    Filed: April 7, 2014
    Date of Patent: April 4, 2017
    Assignee: TEVA Pharmaceutical Industries Limited
    Inventors: Mark Milton-Edwards, Michiel Ullmann
  • Respiratory apparatus
    Patent number: D783805
    Type: Grant
    Filed: April 7, 2014
    Date of Patent: April 11, 2017
    Assignee: TEVA Pharmaceutical Industries Limited
    Inventors: Mark Milton-Edwards, Michiel Ullmann
  • Respiratory apparatus
    Patent number: D783806
    Type: Grant
    Filed: April 7, 2014
    Date of Patent: April 11, 2017
    Assignee: TEVA Pharmaceutical Industries Limited
    Inventors: Mark Milton-Edwards, Michiel Ullmann